These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 9197878)
1. The effect of long-term oestradiol implantation on bone mineral density in postmenopausal women who have undergone hysterectomy and bilateral oophorectomy. Wahab M; Ballard P; Purdie DW; Cooper A; Willson JC Br J Obstet Gynaecol; 1997 Jun; 104(6):728-31. PubMed ID: 9197878 [TBL] [Abstract][Full Text] [Related]
2. The dose-response of percutaneous oestradiol implants on the skeletons of postmenopausal women. Studd JW; Holland EF; Leather AT; Smith RN Br J Obstet Gynaecol; 1994 Sep; 101(9):787-91. PubMed ID: 7947528 [TBL] [Abstract][Full Text] [Related]
3. Effects of natural menopause, hysterectomy, and oophorectomy on lumbar spine and femoral neck bone densities. Hreshchyshyn MM; Hopkins A; Zylstra S; Anbar M Obstet Gynecol; 1988 Oct; 72(4):631-8. PubMed ID: 3419740 [TBL] [Abstract][Full Text] [Related]
4. Increase in bone mass of older postmenopausal women with low mineral bone density after one year of percutaneous oestradiol implants. Holland EF; Leather AT; Studd JW Br J Obstet Gynaecol; 1995 Mar; 102(3):238-42. PubMed ID: 7794850 [TBL] [Abstract][Full Text] [Related]
5. The effect of oestradiol implants on regional and total bone mass: a three-year longitudinal study. Ryde SJ; Bowen-Simpkins K; Bowen-Simpkins P; Evans WD; Morgan WD; Compston JE Clin Endocrinol (Oxf); 1994 Jan; 40(1):33-8. PubMed ID: 8306478 [TBL] [Abstract][Full Text] [Related]
6. Long-term compliance with estrogen replacement therapy in surgical postmenopausal women: benefits to bone and analysis of factors associated with discontinuation. Castelo-Branco C; Figueras F; Sanjuan A; Vicente JJ; Martínez de Osaba MJ; Pons F; Balasch J; Vanrell JA Menopause; 1999; 6(4):307-11. PubMed ID: 10614677 [TBL] [Abstract][Full Text] [Related]
7. Maintained bone density at advanced ages after long term treatment with low dose oestradiol implants. Naessén T; Persson I; Thor L; Mallmin H; Ljunghall S; Bergström R Br J Obstet Gynaecol; 1993 May; 100(5):454-9. PubMed ID: 8518246 [TBL] [Abstract][Full Text] [Related]
8. Oophorectomy status and bone density in older, hysterectomized women. Kritz-Silverstein D; Barrett-Connor E Am J Prev Med; 1996; 12(5):424-9. PubMed ID: 8909657 [TBL] [Abstract][Full Text] [Related]
9. Effects on bone mass after eight years of hormonal replacement therapy. Eiken P; Nielsen SP; Kolthoff N Br J Obstet Gynaecol; 1997 Jun; 104(6):702-7. PubMed ID: 9197874 [TBL] [Abstract][Full Text] [Related]
10. Long-term effects of percutaneous estradiol on bone loss and bone metabolism in postmenopausal hysterectomized women. Devogelaer JP; Lecart C; Dupret P; De Nayer P; Nagant De Deuxchaisnes C Maturitas; 1998 Jan; 28(3):243-9. PubMed ID: 9571600 [TBL] [Abstract][Full Text] [Related]
11. Bone density in women receiving depot medroxyprogesterone acetate for contraception. Cundy T; Evans M; Roberts H; Wattie D; Ames R; Reid IR BMJ; 1991 Jul; 303(6793):13-6. PubMed ID: 1830502 [TBL] [Abstract][Full Text] [Related]
12. The effect of 25-mg percutaneous estradiol implants on the bone mass of postmenopausal women. Holland EF; Leather AT; Studd JW Obstet Gynecol; 1994 Jan; 83(1):43-6. PubMed ID: 8272305 [TBL] [Abstract][Full Text] [Related]
13. Bone remodeling and structure in postmenopausal women treated with long-term, high-dose estrogen therapy. Vedi S; Purdie DW; Ballard P; Bord S; Cooper AC; Compston JE Osteoporos Int; 1999; 10(1):52-8. PubMed ID: 10501780 [TBL] [Abstract][Full Text] [Related]
14. Hysterectomy and oophorectomy are unrelated to bone loss in older women. Kritz-Silverstein D; von Mühlen DG; Barrett-Connor E Maturitas; 2004 Jan; 47(1):61-9. PubMed ID: 14706767 [TBL] [Abstract][Full Text] [Related]
15. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. Gallagher JC; Fowler SE; Detter JR; Sherman SS J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787 [TBL] [Abstract][Full Text] [Related]
16. Dual-energy x-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats. Sato M; McClintock C; Kim J; Turner CH; Bryant HU; Magee D; Slemenda CW J Bone Miner Res; 1994 May; 9(5):715-24. PubMed ID: 8053401 [TBL] [Abstract][Full Text] [Related]
17. Bone mineral density in surgically postmenopausal women receiving hormonal replacement therapy as assessed by dual photon absorptiometry. Castelo-Branco C; Pons F; González-Merlo J Maturitas; 1993 Mar; 16(2):133-7. PubMed ID: 8483425 [TBL] [Abstract][Full Text] [Related]
18. Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. Powles TJ; Hickish T; Kanis JA; Tidy A; Ashley S J Clin Oncol; 1996 Jan; 14(1):78-84. PubMed ID: 8558225 [TBL] [Abstract][Full Text] [Related]
19. Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial. Cheung AM; Tile L; Cardew S; Pruthi S; Robbins J; Tomlinson G; Kapral MK; Khosla S; Majumdar S; Erlandson M; Scher J; Hu H; Demaras A; Lickley L; Bordeleau L; Elser C; Ingle J; Richardson H; Goss PE Lancet Oncol; 2012 Mar; 13(3):275-84. PubMed ID: 22318095 [TBL] [Abstract][Full Text] [Related]
20. The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women. Grey AB; Stapleton JP; Evans MC; Tatnell MA; Ames RW; Reid IR Am J Med; 1995 Dec; 99(6):636-41. PubMed ID: 7503087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]